General MedicationsORALGeneric
NIZATIDINE
NIZATIDINE
Standard Dose
15MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview NIZATIDINE is listed in Drugs@FDA under application 090576 (ANDA).
Marketing status: Discontinued Active ingredient NIZATIDINE Form and strength SOLUTION;ORAL - 15MG/ML Sponsor AMNEAL PHARMS Submission history Latest submission status date: 2009-11-18 00:00:00.
Structured Monograph
Clinical summary
Approval overview NIZATIDINE is listed in Drugs@FDA under application 090576 (ANDA). Marketing status: Discontinued Active ingredient NIZATIDINE Form and strength SOLUTION;ORAL - 15MG/ML Sponsor AMNEAL PHARMS Submission history Latest submission status date: 2009-11-18 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.